Investor List:

Top Drug Delivery Series A Investors in Los Angeles / Southern California

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Samir Mitragotri, Venture Partner at Catalio Capital
Samir Mitragotri
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Santa Barbara (CA), Investors in Boston (MA), Investors in Cambridge (MA)
Photo of Sangeeta N. Bhatia, Venture Partner at Catalio Capital
Sangeeta N. Bhatia
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts, Investors in San Diego (CA), Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Material Science (Seed), Investors in AI (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Seattle / Portland (Other Lists), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Space (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Space (Series A), Investors in AI (Series B), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in British Columbia (Other Lists), Investors in Space (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Series B), Investors in Space (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Therapeutics (Series A), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in AI (Seed)
Photo of Claes Wahlestedt, PhD, MD, Vice President at Pacific Biosciences
Claes Wahlestedt, PhD, MD
Pacific Biosciences·Vice President
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in Boston (MA), Investors in San Diego (CA), Investors in New York (NY), Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diagnostics (Seed), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series A)
Get new data & insights delivered to your inbox